Hyperion DeFi, Inc. (HYPD)
2.08
-0.26
(-11.11%)
USD |
NASDAQ |
Nov 20, 16:00
2.08
0.00 (0.00%)
After-Hours: 20:00
Hyperion DeFi Research and Development Expense (TTM) : 0.5365M for Sept. 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.5365M |
| June 30, 2026 | 0.9081M |
| March 31, 2026 | 1.524M |
| December 31, 2025 | 1.910M |
| September 30, 2025 | 3.469M |
| June 30, 2025 | 6.278M |
| March 31, 2025 | 9.907M |
| December 31, 2024 | 13.33M |
| September 30, 2024 | 15.37M |
| June 30, 2024 | 15.45M |
| March 31, 2024 | 13.96M |
| December 31, 2023 | 12.38M |
| September 30, 2023 | 10.80M |
| June 30, 2023 | 11.41M |
| March 31, 2023 | 12.19M |
| December 31, 2022 | 13.38M |
| September 30, 2022 | 14.35M |
| June 30, 2022 | 13.94M |
| Date | Value |
|---|---|
| March 31, 2022 | 13.97M |
| December 31, 2021 | 14.51M |
| September 30, 2021 | 14.68M |
| June 30, 2021 | 14.58M |
| March 31, 2021 | 13.88M |
| December 31, 2020 | 13.26M |
| September 30, 2020 | 13.24M |
| June 30, 2020 | 13.08M |
| March 31, 2020 | 13.73M |
| December 31, 2019 | 14.10M |
| September 30, 2019 | 14.90M |
| June 30, 2019 | 14.18M |
| March 31, 2019 | 13.02M |
| December 31, 2018 | 11.10M |
| September 30, 2018 | 8.655M |
| June 30, 2018 | 7.076M |
| March 31, 2018 | 5.651M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| EyePoint, Inc. | 296.65M |
| ANI Pharmaceuticals, Inc. | 50.60M |
| Corcept Therapeutics, Inc. | 241.72M |
| Veru, Inc. | 11.76M |
| Johnson & Johnson | 16.02B |